Back
Xeris Biopharma Holdings Stock Price Chart
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).
Buy
69
XERS
Xeris Biopharma Holdings
Last Price:
1.88
Seasonality Move:
-5.66%
7 Day Trial
ALL ACCESS PASS
$
7
Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!
Act now for your path to extra income!- The current trend is relatively stagnant and XERS is experiencing slight buying pressure.
Xeris Biopharma Holdings Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.78 | Buy |
| 20-day SMA: | 1.83 | Buy |
| 50-day SMA: | 2.18 | Sell |
| 200-day SMA: | 2.18 | Sell |
| 8-day EMA: | 1.81 | Buy |
| 20-day EMA: | 1.86 | Buy |
| 50-day EMA: | 2.07 | Sell |
| 200-day EMA: | 2.18 | Sell |
Xeris Biopharma Holdings Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 47.39 | Sell |
| Chaikin Money Flow: | 124991 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.74 - 2.02) | Buy |
| Bollinger Bands (100): | (1.92 - 2.78) | Sell |
Xeris Biopharma Holdings Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Xeris Biopharma Holdings Stock
Is Xeris Biopharma Holdings Stock a Buy?
- Xeris Biopharma Holdings share price is 1.89 while XERS 8-day simple moving average is 1.78, which is a Buy signal.
- The stock price of XERS is 1.89 while Xeris Biopharma Holdings 20-day SMA is 1.83, which makes it a Buy.
- Xeris Biopharma Holdings 50-day simple moving average is 2.18 while XERS share price is 1.89, making it a Sell technically.
- XERS stock price is 1.89 and Xeris Biopharma Holdings 200-day simple moving average is 2.18, creating a Sell signal.
XERS Technical Analysis vs Fundamental Analysis
Buy
69
Xeris Biopharma Holdings (XERS)
is a Buy
Is Xeris Biopharma Holdings a Buy or a Sell?
-
Xeris Biopharma Holdings stock is rated a Buy
The current Xeris Biopharma Holdings [XERS] share price is $1.89. The Score for XERS is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
Xeris Biopharma Holdings Stock Info
Market Cap:
280.2M
Price in USD:
1.89
Share Volume:
1.12M
Xeris Biopharma Holdings 52-Week Range
52-Week High:
3.26
52-Week Low:
1.46
Buy
69
Xeris Biopharma Holdings (XERS)
is a Buy
Xeris Biopharma Holdings Share Price Forecast
-
What is the Xeris Biopharma Holdings stock price today?
The Xeris Biopharma Holdings stock price is 1.89 USD today. -
Will XERS stock go up or go down?
Xeris Biopharma Holdings> share price is forecast to RISE/FALL based on technical indicators -
Is Xeris Biopharma Holdings overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Xeris Biopharma Holdings is not overvalued.
Is Xeris Biopharma Holdings Stock a Buy?
- Xeris Biopharma Holdings share price is 1.89 while XERS 8-day exponential moving average is 1.81, which is a Buy signal.
- The stock price of XERS is 1.89 while Xeris Biopharma Holdings 20-day EMA is 1.86, which makes it a Buy.
- Xeris Biopharma Holdings 50-day exponential moving average is 2.07 while XERS share price is 1.89, making it a Sell technically.
- XERS stock price is 1.89 and Xeris Biopharma Holdings 200-day simple moving average is 2.18, creating a Sell signal.
Fundamental Analysis of Xeris Biopharma Holdings
Is Xeris Biopharma Holdings a good investment?
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and an increase next year of $0.20 per share.
Technical Analysis of Xeris Biopharma Holdings
Should I short Xeris Biopharma Holdings stock?
- XERS Moving Average Covergence Divergence (MACD) indicator is -0.1, suggesting Xeris Biopharma Holdings is a Sell
- Xeris Biopharma Holdings Relative Strength Index (RSI) is 47.39, which suggest Xeris Biopharma Holdings is oversold
- The Bollinger Bands (25) for Xeris Biopharma Holdings is (1.74 - 2.02), which suggest Xeris Biopharma Holdings is a Sell
- The Bollinger Bands (100) for Xeris Biopharma Holdings is (1.92 - 2.78), which suggest Xeris Biopharma Holdings is a Sell
* Xeris Biopharma Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.